JG
BEAT

Jefferies Group’s BioTelemetry, Inc. BEAT Stock Holding History

Jefferies Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,971
Closed -$239K – 3264
2019
Q2 		$239K Buy
+4,971
New +$261K ﹤0.01% 2040
2015
Q3 		– Sell
-2,297
Closed -$22K – 3734
2015
Q2 		$22K Buy
+2,297
New +$21.3K ﹤0.01% 2606

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Jefferies Group's BEAT Position: Q3 2019 in Review

Jefferies Group sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 4,971 shares — an estimated $239K sold.

Jefferies Group first reported a position in BEAT in Q2 2015 and held it in 2 quarters. The position peaked at $239K in Q2 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Jefferies Group reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 4,971 BioTelemetry, Inc. shares in Q3 2019, an estimated $239K.
  • Jefferies Group first reported a position in BioTelemetry, Inc. in Q2 2015 and held it in 2 quarters.
  • Jefferies Group's BioTelemetry, Inc. position peaked at $239K in Q2 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.